Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers

K Öztürk, G Esendağlı, MU Gürbüz, M Tülü… - International journal of …, 2017 - Elsevier
Tumor-targeted delivery of anticancer drugs using dendrimers has been recognized as a
promising strategy to increase efficiency and reduce adverse effects of chemotherapy …

Tumor-induced myeloid cells are reduced by gemcitabine-loaded PAMAM dendrimers decorated with anti-Flt1 antibody

D Yoyen-Ermis, K Ozturk, MA Kursunel… - Molecular …, 2018 - ACS Publications
While reshaping their microenvironment, tumors are also capable of influencing systemic
processes including myeloid cell production. Therefore, the tumor-induced myeloid cells …

PEGylated dendrimer-doxorubicin cojugates as pH-sensitive drug delivery systems: synthesis and in vitro characterization

W She, D Pan, K Luo, B He, G Cheng… - Journal of …, 2015 - ingentaconnect.com
To achieve liver-specific delivery of antitumor drug doxorubicin (DOX), PEGylated dendrimer-
DOX conjugates were designed and synthesized, whereas DOX was conjugated to …

Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy

C Zhang, D Pan, J Li, J Hu, A Bains, N Guys, H Zhu… - Acta biomaterialia, 2017 - Elsevier
Stimuli-responsive peptide dendrimer-drug conjugates have presented significant potential
for cancer therapy. To develop an effective nanoscale chemotherapeutic prodrug, we …

Enzyme-triggered transcytosis of dendrimer–drug conjugate for deep penetration into pancreatic tumors

G Wang, Z Zhou, Z Zhao, Q Li, Y Wu, S Yan, Y Shen… - ACS …, 2020 - ACS Publications
The dense fibrotic stroma in pancreatic ductal adenocarcinoma (PDA) resists drug diffusion
into the tumor and leads to an unsatisfactory prognosis. To address this problem, we …

Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer

J Liu, C Chen, T Wei, O Gayet, C Loncle, L Borge… - …, 2021 - Wiley Online Library
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer with no efficacious treatment.
The application of nanomedicine is expected to bring new hope to PDAC treatment. In this …

The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers

S Thakur, RK Tekade, P Kesharwani… - Journal of Nanoparticle …, 2013 - Springer
The objective of the present investigation was to assess the tumor-targeting potential of
ligand-spacer-engineered poly (propylene imine)(PPI) dendrimers as nanoscale drug …

EGF-coated nano-dendriplexes for tumor-targeted nucleic acid delivery in vivo

J Li, L Chen, N Liu, S Li, Y Hao, X Zhang - Drug delivery, 2016 - Taylor & Francis
The clinical success of therapeutic DNA is still hindered due to the lack of effective delivery
carriers. Here, we designed a tumor-targeted gene nano delivery system based on EGFR …

Formulation Development and In VitroIn Vivo Assessment of The Fourth-Generation Ppi Dendrimer as A Cancer-Targeting Vector

P Kesharwani, RK Tekade, NK Jain - Nanomedicine, 2014 - Taylor & Francis
Aim: In spite of numerous biopharmaceutical applications of fifth-generation poly
(propyleneimine)(PPI) dendrimers, inherent toxicity due to the presence of many peripheral …

Dendrimer-based nanocarriers demonstrating a high efficiency for loading and releasing anticancer drugs against cancer cells in vitro and in vivo

NQ Tran, CK Nguyen, TP Nguyen - Advances in Natural …, 2013 - iopscience.iop.org
Dendrimer, a new class of hyper-branched polymer with predetermined molecular weight
and well-controlled size, has received much attention in nanobiomedical applications such …